当前位置:首页 - 行情中心 - 东方生物(688298) - 财务分析 - 现金流量表

东方生物

(688298)

  

流通市值:50.28亿  总市值:50.28亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金459,201,097.93244,090,639.16849,074,992.51630,249,410.12
  收到的税费返还22,165,227.6510,770,706.2749,586,315.940,298,464.02
  收到其他与经营活动有关的现金39,005,893.9721,161,222.53239,285,334.3899,586,729.82
  经营活动现金流入小计520,372,219.55276,022,567.961,137,946,642.79770,134,603.96
  购买商品、接受劳务支付的现金219,447,428.8105,619,754.22585,681,072.37443,995,387
  支付给职工以及为职工支付的现金247,738,027.65128,596,882.82529,610,957.96386,811,547.1
  支付的各项税费26,030,220.6514,221,291.2835,996,630.7436,197,527.4
  支付其他与经营活动有关的现金150,427,133.4381,873,249.81334,984,837.04270,282,997.04
  经营活动现金流出小计643,642,810.53330,311,178.131,486,273,498.111,137,287,458.54
  经营活动产生的现金流量净额-123,270,590.98-54,288,610.17-348,326,855.32-367,152,854.58
二、投资活动产生的现金流量:
  收回投资收到的现金263,200,517.99163,727,360996,479,507.58471,796,330
  取得投资收益收到的现金818,920.01668,546.1430,259,041.8848,387,458.12
  处置固定资产、无形资产和其他长期资产收回的现金净额300,142.4554,449.457,514,070.0976,650
  收到的其他与投资活动有关的现金2,686,177,147.781,301,988,103.733,915,211,953.992,843,171,247.44
  投资活动现金流入小计2,950,496,728.231,466,438,459.324,949,464,573.543,363,431,685.56
  购建固定资产、无形资产和其他长期资产支付的现金207,589,449.21152,705,711.63924,094,818.92501,658,538.02
  投资支付的现金380,366,804.87309,503,360318,224,495.4224,029,728.67
  取得子公司及其他营业单位支付的现金00320,760,237.18322,414,102
  支付其他与投资活动有关的现金2,159,142,202.611,294,856,303.14,056,534,814.462,568,913,520
  投资活动现金流出小计2,747,098,456.691,757,065,374.735,619,614,365.963,617,015,888.69
  投资活动产生的现金流量净额203,398,271.54-290,626,915.41-670,149,792.42-253,584,203.13
三、筹资活动产生的现金流量:
  吸收投资收到的现金00360,000360,000
  其中:子公司吸收少数股东投资收到的现金--360,000360,000
  取得借款收到的现金271,000,000239,000,000300,750,000290,700,000
  收到其他与筹资活动有关的现金00--
  筹资活动现金流入小计271,000,000239,000,000301,110,000291,060,000
  偿还债务支付的现金406,000,000364,000,000431,700,000351,600,000
  分配股利、利润或偿付利息支付的现金3,593,697.652,046,598.6116,631,227.3810,939,543.43
  其中:子公司支付给少数股东的股利、利润0---
  支付其他与筹资活动有关的现金9,773,839.092,936,600.39304,516,084.05303,507,693.14
  筹资活动现金流出小计419,367,536.74368,983,199752,847,311.43666,047,236.57
  筹资活动产生的现金流量净额-148,367,536.74-129,983,199-451,737,311.43-374,987,236.57
四、汇率变动对现金及现金等价物的影响1,645,378.843,253,774.5151,885,915.889,889,480.5
五、现金及现金等价物净增加额-66,594,477.34-471,644,950.07-1,418,328,043.29-985,834,813.78
  加:期初现金及现金等价物余额1,510,275,298.881,510,275,298.882,928,603,342.172,928,603,342.17
  期末现金及现金等价物余额1,443,680,821.541,038,630,348.811,510,275,298.881,942,768,528.39
补充资料:
  净利润-174,059,798.07--568,822,462.49-
  资产减值准备13,924,362.69-175,703,291.62-
  固定资产和投资性房地产折旧46,512,213.64-100,791,302.83-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧46,512,213.64-100,791,302.83-
  无形资产摊销39,389,221.51-80,547,339.31-
  长期待摊费用摊销10,992,251.1-21,985,730.19-
  处置固定资产、无形资产和其他长期资产的损失-1,741,743.14--987,647.61-
  固定资产报废损失80,221.82-171,750.36-
  公允价值变动损失-4,992,565.99--10,654,769.31-
  财务费用-13,603,947.38--45,776,256.97-
  投资损失-3,484,332.15--29,776,712.67-
  递延所得税-252,839.01--22,479,345.91-
  其中:递延所得税资产减少-129,707.65--22,675,987.71-
    递延所得税负债增加-123,131.36-196,641.8-
  存货的减少-18,012,620.13-1,911,558-
  经营性应收项目的减少-42,631.99--109,368,761.14-
  经营性应付项目的增加-26,938,579.16--11,523,909.31-
  其他--15,782,208.33-
  现金的期末余额1,443,680,821.54-1,510,275,298.88-
  减:现金的期初余额1,510,275,298.88-2,928,603,342.17-
  现金及现金等价物的净增加额-66,594,477.34--1,418,328,043.29-
公告日期2025-08-292025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑